Hybio Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange:300199.SZ

Location

Market Cap

USD 2.28 B

Share Price

USD 2.58

Avg Daily Volume

52,721,160

Change (1 day)

1.74%

Change (1 year)

84.61%

Change (YTD)

46.15%

Hybio Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2024: -27.34%

Hybio Pharmaceutical Co., Ltd. Operating Income Margin is -27.34% for the year ending December 31, 2024, a -76.76% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Hybio Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2023 was -117.65%, a 123.46% change year over year.
  • Hybio Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2022 was -52.65%, a -1,090.95% change year over year.
  • Hybio Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2021 was 5.31%, a -106.68% change year over year.
  • Hybio Pharmaceutical Co., Ltd. Operating Income Margin for the year ending December 31, 2020 was -79.58%, a -46.01% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin